Published in Papillomavirus Res on December 01, 2016
A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol (2004) 42.68
Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2007) 13.20
Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males. N Engl J Med (2011) 11.09
Effect of human papillomavirus 16/18 L1 viruslike particle vaccine among young women with preexisting infection: a randomized trial. JAMA (2007) 4.66
Prevention and control of meningococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2005) 4.15
Proof-of-principle evaluation of the efficacy of fewer than three doses of a bivalent HPV16/18 vaccine. J Natl Cancer Inst (2011) 3.92
Human papillomavirus vaccination coverage among adolescents, 2007-2013, and postlicensure vaccine safety monitoring, 2006-2014--United States. MMWR Morb Mortal Wkly Rep (2014) 3.41
Risk of female human papillomavirus acquisition associated with first male sex partner. J Infect Dis (2008) 3.19
Factors associated with HPV vaccine uptake in teenage girls: a systematic review. Vaccine (2012) 2.98
Prevalence of genital human papillomavirus among females in the United States, the National Health And Nutrition Examination Survey, 2003-2006. J Infect Dis (2011) 2.88
Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2006) 2.86
National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years--United States, 2013. MMWR Morb Mortal Wkly Rep (2014) 2.39
Durable antibody responses following one dose of the bivalent human papillomavirus L1 virus-like particle vaccine in the Costa Rica Vaccine Trial. Cancer Prev Res (Phila) (2013) 2.17
Comprehensive control of human papillomavirus infections and related diseases. Vaccine (2013) 1.81
Determining accurate vaccination coverage rates for adolescents: the National Immunization Survey-Teen 2006. Public Health Rep (2009) 1.56
Age of sexual debut among US adolescents. Contraception (2009) 1.47
Sexual initiation, contraceptive use, and pregnancy among young adolescents. Pediatrics (2013) 1.38
Efficacy of the HPV-16/18 vaccine: final according to protocol results from the blinded phase of the randomized Costa Rica HPV-16/18 vaccine trial. Vaccine (2014) 1.02
The early benefits of human papillomavirus vaccination on cervical dysplasia and anogenital warts. Pediatrics (2015) 0.99
Age at HPV vaccine initiation and completion among US adolescent girls: trend from 2008 to 2012. Vaccine (2014) 0.97
Vaccination coverage among U.S. adolescents aged 13-17 years eligible for the Vaccines for Children program, 2009. Public Health Rep (2011) 0.93
Differences in HPV Immunization Levels Among Young Adults in Various Regions of the United States. J Community Health (2015) 0.93
Health disparities in human papillomavirus vaccine coverage: trends analysis from the National Immunization Survey-Teen, 2008-2011. Clin Infect Dis (2013) 0.90
Why are U.S. girls getting meningococcal but not human papilloma virus vaccines? Comparison of factors associated with human papilloma virus and meningococcal vaccination among adolescent girls 2008 to 2012. Womens Health Issues (2015) 0.85
Do parental education and income matter? A nationwide register-based study on HPV vaccine uptake in the school-based immunisation programme in Norway. BMJ Open (2015) 0.77